213 related articles for article (PubMed ID: 993343)
1. The measurement of thrombin in clotting blood by radioimmunoassay.
Shuman MA; Majerus PW
J Clin Invest; 1976 Nov; 58(5):1249-58. PubMed ID: 993343
[TBL] [Abstract][Full Text] [Related]
2. Formation of the fibrin clot: the balance of procoagulant and inhibitory factors.
Lämmle B; Griffin JH
Clin Haematol; 1985 Jun; 14(2):281-342. PubMed ID: 2994929
[TBL] [Abstract][Full Text] [Related]
3. Relationship between secretion of platelet Factor 4 and thrombin generation during in vitro blood clotting.
Shuman MA; Levine SP
J Clin Invest; 1980 Feb; 65(2):307-13. PubMed ID: 6243308
[TBL] [Abstract][Full Text] [Related]
4. On the mechanism of coagulation inhibition on surfaces with end point immobilized heparin.
Elgue G; Blombäck M; Olsson P; Riesenfeld J
Thromb Haemost; 1993 Aug; 70(2):289-93. PubMed ID: 8236137
[TBL] [Abstract][Full Text] [Related]
5. Pharmacologic modulation of thrombin generation associated with human clots by human purified antithrombin alone or in the presence of low molecular weight heparin or unfractionated heparin.
Meddahi S; Bara L; Fessi H; Samama MM
Blood Coagul Fibrinolysis; 2000 Jan; 11(1):51-9. PubMed ID: 10691099
[TBL] [Abstract][Full Text] [Related]
6. Heparin and low molecular weight heparins inhibit prothrombinase formation but not its activity in plasma.
Ofosu FA; Lormeau JC; Craven S; Dewar L; Anvari N
Thromb Haemost; 1994 Dec; 72(6):862-8. PubMed ID: 7740455
[TBL] [Abstract][Full Text] [Related]
7. Prothrombin fragment 1 + 2, thrombin-antithrombin III-complexes and fibrinopeptide A in spontaneously clotting whole blood in vitro. Effects of heparin addition and antithrombin III deficiency.
Herren T; Straub PW; Haeberli A
Thromb Haemost; 1994 Jan; 71(1):49-53. PubMed ID: 8165646
[TBL] [Abstract][Full Text] [Related]
8. Thrombin generation and secretion of platelet Factor 4 during blood clotting.
Shuman MA; Levine SP
J Clin Invest; 1978 Apr; 61(4):1102-6. PubMed ID: 207723
[TBL] [Abstract][Full Text] [Related]
9. Antithrombin III. Theory and clinical applications. H. P. Smith Memorial Lecture.
Seegers WH
Am J Clin Pathol; 1978 Apr; 69(4):299-359. PubMed ID: 347919
[TBL] [Abstract][Full Text] [Related]
10. [Intracranial hemorrhage and hemostasis. Monitoring patients after intracranial hemorrhage by determination and follow-up of activation products of blood coagulation].
Menges T; von Lessen A; Welters I; Wagner RM; Ruwoldt R; Boldt J; Hempelmann G
Infusionsther Transfusionsmed; 1994 Aug; 21(4):244-50. PubMed ID: 7950289
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of prothrombin activation by bothrojaracin, a C-type lectin from Bothrops jararaca venom.
Monteiro RQ; Zingali RB
Arch Biochem Biophys; 2000 Oct; 382(1):123-8. PubMed ID: 11051105
[TBL] [Abstract][Full Text] [Related]
12. [Heparin assay in plasma. Comparison of different methods (author's transl)].
Vinazzer H
Anaesthesist; 1979 Jun; 28(6):299-303. PubMed ID: 464252
[TBL] [Abstract][Full Text] [Related]
13. Acetylated prothrombin as a substrate in the measurement of the procoagulant activity of platelets: elimination of the feedback activation of platelets by thrombin.
Jesty J; Bluestein D
Anal Biochem; 1999 Jul; 272(1):64-70. PubMed ID: 10405294
[TBL] [Abstract][Full Text] [Related]
14. Localization of the inhibitory site(s) of pentosan polysulphate in blood coagulation.
Wagenvoord R; Hendrix H; Soria C; Hemker HC
Thromb Haemost; 1988 Oct; 60(2):220-5. PubMed ID: 2464199
[TBL] [Abstract][Full Text] [Related]
15. The effects of hepes buffer on clotting tests, assay of factors V and VIII and on the hydrolysis of esters by thrombin and thrombokinase.
Roberts PS; Hughes HN; Fleming PB
Thromb Haemost; 1976 Feb; 35(1):202-10. PubMed ID: 989187
[TBL] [Abstract][Full Text] [Related]
16. Heparin chain-length dependence of factor Xa inhibition by antithrombin in plasma.
Rezaie AR
Thromb Res; 2007; 119(4):481-8. PubMed ID: 16515805
[TBL] [Abstract][Full Text] [Related]
17. Factor XI enhances fibrin generation and inhibits fibrinolysis in a coagulation model initiated by surface-coated tissue factor.
von dem Borne PA; Cox LM; Bouma BN
Blood Coagul Fibrinolysis; 2006 Jun; 17(4):251-7. PubMed ID: 16651866
[TBL] [Abstract][Full Text] [Related]
18. Development of platelet contractile force as a research and clinical measure of platelet function.
Carr ME
Cell Biochem Biophys; 2003; 38(1):55-78. PubMed ID: 12663942
[TBL] [Abstract][Full Text] [Related]
19. The technique of measuring thrombin generation with fluorogenic substrates: 3. The effects of sample dilution.
De Smedt E; Wagenvoord R; Coen Hemker H
Thromb Haemost; 2009 Jan; 101(1):165-70. PubMed ID: 19132204
[TBL] [Abstract][Full Text] [Related]
20. Postclotting fates of thrombin.
Seegers WH
Semin Thromb Hemost; 1986 Jul; 12(3):181-3. PubMed ID: 3775386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
